Skip to main navigation Skip to search Skip to main content

LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins

  • Damien Zanker
  • , Kenneth Pang
  • , Sara Oveissi
  • , Chunni Lu
  • , Pierre Faou
  • , Cameron Nowell
  • , George W. Mbogo
  • , Sebastian Carotta
  • , Cathy Quillici
  • , Guna Karupiah
  • , Margaret L. Hibbs
  • , Stephen L. Nutt
  • , Paul Neeson
  • , Hamsa Puthalakath
  • , Weisan Chen*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

The role of the immunoproteasome is perceived as confined to adaptive immune responses given its ability to produce peptides ideal for MHC Class-I binding. Here, we demonstrate that the immunoproteasome subunit, LMP2, has functions beyond its immunomodulatory role. Using LMP2-deficient mice, we demonstrate that LMP2 is crucial for lymphocyte development and survival in the periphery. Moreover, LMP2-deficient lymphocytes show impaired degradation of key BH3-only proteins, resulting in elevated levels of pro-apoptotic BIM and increased cell death. Interestingly, LMP2 is the sole immunoproteasome subunit required for BIM degradation. Together, our results suggest LMP2 has important housekeeping functions and represents a viable therapeutic target for cancer.

Original languageEnglish
Pages (from-to)981-993
Number of pages13
JournalImmunology and Cell Biology
Volume96
Issue number9
DOIs
Publication statusPublished - Oct 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'LMP2 immunoproteasome promotes lymphocyte survival by degrading apoptotic BH3-only proteins'. Together they form a unique fingerprint.

Cite this